The integrin binding domain of chondroadherin is a potential new target for drug development to treat bone metastases, affecting the players of the vicious cycle
M. Capulli⁎, A. Rufo, M. Alamanou, O. Kristoffer, K.M. Gautvik, L. Haglund, D. Heinegård, A. Teti, N. RucciVolume:
47
Year:
2010
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2010.04.062
File:
PDF, 55 KB
english, 2010